{
  "name": "HR-/HER2+ Combo Therapy Treatment",
  "states": {

    "Initial": {
      "type": "Initial",
      "direct_transition": "Therapy_Initial_Encounter"
    },

    "Therapy_Initial_Encounter": {
      "type": "Encounter",
      "remarks": [
        "This is the initial encounter to begin 'combo' encodrine + chemo ",
        "therapy. For chemotherapy the patient is prescribed either Pertuzimab, ",
        "Trastuzimab, or Taxane. For endocrine therapy, the patient is prescribed ",
        "either Anastrazole or Tamoxifen depending on her age."
      ],
      "encounter_class": "ambulatory",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "308335008",
          "display": "Patient encounter procedure"
        }
      ],
      "direct_transition": "Select_Chemotherapy_Drug"
    },

    "Select_Chemotherapy_Drug": {
      "type": "Simple",
      "distributed_transition": [
        {
          "distribution": 0.34,
          "transition": "Prescribe_Pertuzimab"
        },
        {
          "distribution": 0.33,
          "transition": "Prescribe_Trastuzimab"
        },
        {
          "distribution": 0.33,
          "transition": "Prescribe_Taxane"
        }
      ]
    },

    "Prescribe_Pertuzimab": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": "1298948",
          "display": "14 ML pertuzumab 30 MG/ML Injection"
        }
      ],
      "direct_transition": "Select_Endocrine_Therapy_Drug"
    },

    "Prescribe_Trastuzimab": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": "1922509",
          "display": "Trastuzumab 150 MG Injection"
        }
      ],
      "direct_transition": "Select_Endocrine_Therapy_Drug"
    },

    "Prescribe_Taxane": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": "583214",
          "display": "PACLitaxel 100 MG Injection"
        }
      ],
      "direct_transition": "Select_Endocrine_Therapy_Drug"
    },

    "Select_Endocrine_Therapy_Drug": {
      "type": "Simple",
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Age",
            "operator": ">=",
            "quantity": 50,
            "unit": "years"
          },
          "transition": "Prescribe_Anastrazole"
        },
        {
          "transition": "Prescribe_Tamoxifen"
        }
      ]
    },

    "Prescribe_Anastrazole": {
      "type": "MedicationOrder",
      "reason": "Stage_IV_Breast_Cancer",
      "codes": [
        {
          "system": "RxNorm",
          "code": "199224",
          "display": "Anastrazole 1MG Oral Tablet"
        }
      ],
      "direct_transition": "Baseline_Exam"
    },

    "Prescribe_Tamoxifen": {
      "type": "MedicationOrder",
      "reason": "Stage_IV_Breast_Cancer",
      "codes": [
        {
          "system": "RxNorm",
          "code": "198240",
          "display": "Tamoxifen 10MG Oral Tablet"
        }
      ],
      "direct_transition": "Baseline_Exam"
    },

    "Baseline_Exam": {
      "type": "CallSubmodule",
      "submodule": "metastatic_breast_cancer/full_exam",
      "direct_transition": "End_Therapy_Initial_Encounter"
    },

    "End_Therapy_Initial_Encounter": {
      "type": "EncounterEnd",
      "direct_transition": "Combo_Therapy_Cycle"
    },

    "Combo_Therapy_Cycle": {
      "type": "Delay",
      "exact": {
        "quantity": 8,
        "unit": "weeks"
      },
      "direct_transition": "Combo_Therapy_Check_Up"
    },

    "Combo_Therapy_Check_Up": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "direct_transition": "Routine_Exam"
    },

    "Routine_Exam": {
      "type": "CallSubmodule",
      "submodule": "procedures/metastatic_breast_cancer/full_exam",
      "direct_transition": "End_Combo_Therapy_Check_Up"
    },

    "End_Combo_Therapy_Check_Up": {
      "type": "EncounterEnd",
      "direct_transition": "Progression?"
    },

    "Progression?": {
      "type": "Simple",
      "remarks": [
        "50% of patients have a 1st progression by 9 months. Given 8 weeks/cycle, ",
        "that's roughly 5 cycles before 50% of patients have progressed.",
        "Model: P(progression) = 0.87 ^ n_cycles "
      ],
      "distributed_transition": [
        {
          "distribution": 0.87,
          "transition": "Combo_Therapy_Cycle"
        },
        {
          "distribution": 0.13,
          "transition": "First_Progression"
        }
      ]
    },

    "First_Progression": {
      "type": "Simple",
      "direct_transition": "Living_With_Progressing_Metastatic_Breast_Cancer"
    },

    "Living_With_Progressing_Metastatic_Breast_Cancer": {
      "type": "Simple",
      "direct_transition": "Diminishing_Likelihood_Of_Survival"
    },

    "Diminishing_Likelihood_Of_Survival": {
      "type": "Delay",
      "remarks": [
        "Annual chances of survival decay exponentially. 50% of patients die ",
        "within 48 months of their first progression.",
        "Model: P(survival) = .84 ^ n_years "
      ],
      "exact": {
        "quantity": 1,
        "unit": "years"
      },
      "distributed_transition": [
        {
          "distribution": 0.84,
          "transition": "Living_With_Progressing_Metastatic_Breast_Cancer"
        },
        {
          "distribution": 0.16,
          "transition": "Death"
        }
      ]
    },

    "Death": {
      "type": "Death",
      "direct_transition": "Terminal"
    },

    "Terminal": {
      "type": "Terminal"
    }
  }
}
